6-Chloro-5-fluoro-2'-methylspiro[benzo[d][1,3]oxazine-4,3'-piperidin]-2(1H)-one hydrochloride

Catalog No. :
ACODHC203
CAS No. :
2228305-61-9
Molecular Formula :
C13H15Cl2FN2O2
Molecular Weight :
321.18

IUPAC Name:6-chloro-5-fluoro-2'-methylspiro[benzo[d][1,3]oxazine-4,3'-piperidin]-2(1H)-one hydrochloride

6-Chloro-5-fluoro-2'-methylspiro[benzo[d][1,3]oxazine-4,3'-piperidin]-2(1H)-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$687.00Login to see priceInquiryInquiry
100mg98%$891.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-5-fluoro-2'-methylspiro[benzo[d][1,3]oxazine-4,3'-piperidin]-2(1H)-one hydrochloride
IUPAC Name6-chloro-5-fluoro-2'-methylspiro[benzo[d][1,3]oxazine-4,3'-piperidin]-2(1H)-one hydrochloride
MDL No.MFCD31666542
Molecular FormulaC13H15Cl2FN2O2
Molecular Weight321.18
SMILESO=C1NC2=CC=C(Cl)C(F)=C2C3(C(C)NCCC3)O1.[H]Cl
InChI KeyJQZMDGUMVOBRAB-UHFFFAOYSA-N
Synonym6-chloro-5-fluoro-2''-methyl-1,2-dihydrospiro[3,1-benzoxazine-4,3''-piperidine]-2-one hydrochloride;Spiro[4H-3,1-benzoxazine-4,3′-piperidin]-2(1H)-one, 6-chloro-5-fluoro-2′-methyl-, hydrochloride (1:1)
CAS No.2228305-61-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACODHC203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACODHC203 route product structure diagram
    ACODHC2032228305-61-9
Inquiry

2. ACODHC203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACODHC203 route product structure diagram
    ACODHC2032228305-61-9
Inquiry

Comments (0)